A roadmap toward promoting and improving brain health in Europe and closing the awareness and funding gap
Jazyk angličtina Země Velká Británie, Anglie Médium print
Typ dokumentu časopisecké články, přehledy
PubMed
39815708
PubMed Central
PMC11735729
DOI
10.1111/ene.16589
Knihovny.cz E-zdroje
- Klíčová slova
- brain, brain health, burden, neurology, strategy,
- MeSH
- lidé MeSH
- mozek MeSH
- nemoci nervového systému * terapie MeSH
- podpora zdraví MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
- Geografické názvy
- Evropa MeSH
BACKGROUND AND PURPOSE: The global burden of neurological diseases exceeds 43.1%, imposing a significant burden on patients, caregivers and society. This paper presents a roadmap to reduce this burden and improve brain health (BH) in Europe. METHODS: The roadmap is based on the European Academy of Neurology's (EAN) five-pillar BH strategy: advancing a global BH approach (P1), supporting policymaking (P2), fostering research (P3), promoting education (P4), and raising awareness of prevention and treatment (P5). It reviews current efforts, collaborations and future directions aligned with the WHO Intersectoral Global Action Plan (iGAP) for Neurological Disorders and suggests future initiatives and call for action. RESULTS: P1: Support WHO-iGAP through defined action points, international collaborations, in particular, the WHO BH Unit, and the EAN Brain Health Mission. P2: Collaborate with 48 national neurological societies to promote National Brain Plans (NBPs), addressing local needs, and improving access to care. P3: Advocate for more research funding; identify determinants of BH; develop preventive measures. P4: Provide educational opportunities for neurologists, public education programs, and advocacy training, including tools to educate the public. P5: Spearhead global awareness campaigns, organize public educational activities, and train BH advocates to contribute toward sustainable and long-term public health campaigns and policy engagement. CONCLUSIONS: The paper highlights the importance of a unified approach, integrating international collaborations and local initiatives, to improve BH outcomes based on the WHO-iGAP, and support sustainable development goals, in particular SDG 3: Good Health and Well-being and SDG 4: Quality Education.
Brain and Mind Research Central European Institute of Technology Masaryk University Brno Czechia
Department of Neurology and 4Brain Ghent University Hospital Ghent Belgium
Department of Neurology Inselspital University of Bern Bern Switzerland
Department of Pharmacology and Therapeutics University of Liverpool Liverpool UK
Eindhoven University of Technology Eindhoven The Netherlands
European Academy of Neurology Vienna Austria
Zobrazit více v PubMed
GBD 2021 Nervous System Disorders Collaborators . Global, regional, and national burden of disorders affecting the nervous system, 1990‐2021: a systematic analysis for the global burden of disease study 2021. The Lancet Neurology. 2024;23(4):344‐381. doi:10.1016/S1474-4422(24)00038-3 PubMed DOI PMC
GBD 2019 Mental Disorders Collaborators . Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990‐2019: a systematic analysis for the global burden of disease study 2019. Lancet Psychiatry. 2022;9(2):137‐150. doi:10.1016/S2215-0366(21)00395-3 PubMed DOI PMC
Deuschl G, Beghi E, Fazekas F, et al. The burden of neurological diseases in Europe: an analysis for the global burden of disease study 2017. Lancet Public Health. 2020;5(10):e551‐e567. doi:10.1016/S2468-2667(20)30190-0 PubMed DOI
Tramonti F, Bonfiglio L, Bongioanni P, et al. Caregiver burden and family functioning in different neurological diseases. Psychol Health Med. 2019;24(1):27‐34. doi:10.1080/13548506.2018.1510131 PubMed DOI
Sex, gender, and the cost of neurological disorders, editorial. Lancet Neurol. 2023;22‐5:367. PubMed
Dodel R, Boon P, et al. Cost of Neurological Disorders in Europe—COIN‐EU. Unpublished study; 2024. https://www.ean.org/research/projects/economic‐burden‐of‐neurological‐diseases‐in‐europe
Economist Impact–The Value of Action: Mitigating the global impact of neurological disorders. https://impact.economist.com/perspectives/sites/default/files/download/the_value_of_action‐_mitigating_the_global_impact_of_neurological_disorders_methodology_sep_2022.pdf
Optimizing brain health across the life course: WHO position paper. https://iris.who.int/bitstream/handle/10665/361251/9789240054561‐eng.pdf?sequence=1
World Health Organisation Intersectoral Global Action Plan on Epilepsy and other Neurological Disorders. https://www.who.int/publications/i/item/9789240076624
Bassetti CLA, Accorroni A, Arnesen A, et al. General neurology: current challenges and future implications. Eur J Neurol. 2024;31(6):e16237. doi:10.1111/ene.16237 PubMed DOI PMC
Eyre HA, Hynes W, Ayadi R, Manes F, Swieboda P. Brain capital is crucial for global sustainable development. Lancet Neurol. 2024;23(3):233‐235. doi:10.1016/S1474-4422(24)00031-0 PubMed DOI
Lock SL. The benefits of brain health to our economies. Nat Aging. 2023;3(1):1‐2. doi:10.1038/s43587-022-00302-z PubMed DOI PMC
Bassetti CLA, Endres M, Sander A, et al. The European academy of neurology brain health strategy: one brain, one life, one approach. Eur J Neurol. 2022;29(9):2559‐2566. doi:10.1111/ene.15391 PubMed DOI
Shared European Brain Research Agenda. https://www.ebra.eu/wp‐content/uploads/2022/03/SEBRA_OpenConsultation.pdf
Rost NS, Salinas J, Jordan JT, et al. The brain health imperative in the 21st century‐a call to action: the AAN brain health platform and position statement. Neurology. 2023;101(13):570‐579. doi:10.1212/WNL.0000000000207739 PubMed DOI PMC
Grisold W, Karlshoej K, Freedman M, et al. Brain health as a global priority, view from WHO: editorial from the world Federation of Neurology. J Neurol Sci. 2022;440:120337. doi:10.1016/j.jns.2022.120337 PubMed DOI
Intersectoral global action plan on epilepsy and other neurological disorders 2022–2031: implementation toolkit. https://www.who.int/publications/i/item/9789240096356 PubMed
The Brain Health Mission. www.brainhealthmission.org
Bassetti CLA, Heldner MR, Adorjan K, et al. The swiss brain health plan 2023–2033. Clinical and Translational Neuroscience. 2023;7(4):38. doi:10.3390/ctn7040038 DOI
Winter SF, Walsh D, Catsman‐Berrevoets C, et al. National plans and awareness campaigns as priorities for achieving global brain health. Lancet Glob Health. 2024;12(4):e697‐e706. doi:10.1016/s2214-109x(23)00598-3 PubMed DOI PMC
EBRA European Research Inventory and Mapping Report. https://www.ebra.eu/mapping‐report/
Bouillon R, Slordahl S, Nogueria MM, et al. Public investment in biomedical reserach in Europe. Lancet. 2015;386:10001‐11335. PubMed
The Lancet Neurology . Neurological burden and European investment: a disconnect. Lancet Neurol. 2021;20(2):81. doi:10.1016/s1474-4422(21)00003-x PubMed DOI
National Institutes of Health (NIH) . Direct Economic Contributions, Research Investment, Annual Review. 2023.
Boon P, Lescrauwaet E, Aleksovska K, et al. A strategic neurological research agenda for Europe: towards clinically relevant and patient‐centered neurological research priorities. Eur J Neurol. 2024;31:16137. PubMed PMC
European Partnership for Brain Health. https://www.brainhealth‐partnerships.eu
European Training Requirements for Neurology. UEMS‐Neuroboard.org
EAN Advocacy Training for Neurology and Brain Health. https://www.ean.org/ean/advocacy/training/ean‐advocacy‐training‐for‐neurology‐and‐brain‐health
Brain Health Mission—Brain Health School Challenge Project. https://www.ean.org/brain‐health‐mission/activities‐events/brain‐health‐school‐challenge‐project
Certificate of Advanced Studies in Brain Health. https://www.unibe.ch/continuing_education_programs/cas_in_brain_health/index_eng.html
Defeating meningitis by 2030, a global road map, WHO. 2021, ISBN 978‐92‐4‐002641‐4.